Clinical Trial

COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 Diabetes

Study acronym: COLCOT-T2D
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
To evaluate the efficacy and safety of colchicine and non-enteric coated aspirin, combined or alone, to improve cardiovascular outcomes in high-risk patients with type 2 diabetes.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2022-11-30; most recent amendment 2026-03-09.
Status change: Not Yet Recruiting → Recruiting 2022-12-20
Trial Details
NCT Number NCT05633810
Lead Sponsor Montreal Heart Institute
Conditions Diabete Type 2, Cardiovascular Diseases
Enrollment 10,000 participants
Start Date 2022-12-21
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-10